Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).

CONCLUSIONS: According to our experience, micafungin is an appropriate alternative for antifungal prophylaxis in patients undergoing an allo-HSCT, because its efficacy, its low profile of drug interactions and side-effects. PMID: 32056418 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32056418?dopt=Abstract

Source: Revista Espanola de Quimioterapia - February 13, 2020 Category: Drugs & Pharmacology Authors: López-Sánchez C, Valcárcel D, Gómez V, López-Jiménez J, Serrano D, Rubio V, Solano C, Vázquez L, Ruiz I, Grupo Español de Trasplante Hematopoyético (GETH) Tags: Rev Esp Quimioter Source Type: research